Nerve-Zapping showdown: which procedure best stops a runny nose?
NCT ID NCT07706595
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This trial compares three FDA-cleared in-office procedures that treat chronic non-allergic rhinitis by targeting the posterior nasal nerve. Radiofrequency ablation (using RhinAer or Neuromark) uses heat, while cryoablation (ClariFix) uses extreme cold to reduce nerve signals that cause runny nose, congestion, and postnasal drip. About 50 adults with chronic rhinitis will be randomly assigned to one of the three treatments and report their symptom changes and quality of life over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- radiofrequency ablation (RhinAer or Neuromark) or cryoablation (ClariFix) of the posterior nasal nerve
- What this could lead to
- If one method proves superior, it could become the preferred in-office procedure for long-term relief from chronic rhinitis symptoms like runny nose and congestion.
- What could go wrong
- This is a small, single-center trial (50 participants) comparing already-approved devices, so differences may be subtle or not generalizable. All procedures carry risks of temporary discomfort, bleeding, or incomplete symptom relief.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 50 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2024
- Expected to finish
-
Aug 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 18 years or older * Diagnosis of chronic rhinitis (non-allergic rhinitis) Exclusion Criteria: \- Under 18 years of age
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic rhinitis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Perlman Medical Office at UC San Diego
La Jolla, California, 92037, United States
-
Veterans Affairs San Diego Healthcare System
San Diego, California, 92161, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Which steroid works better for chronic cough? a Head-to-Head trial aims to find out
- New device zaps nose nerves to stop runny nose
- New nasal spray aims to unblock stuffy noses fast
- Zapping nasal nerves could stop runny noses
- New gel promises Ultra-Fast relief for chronic throat and nose sufferers
- SNIFF TEST: nasal swab may reveal lung disease severity